Entering edit mode
11 weeks ago
Yuri Vainshtein • 180
Date: December 1, 2022 Source: Picower Institute at MIT Summary: Researchers report early stage clinical study results of tests with non-invasive 40Hz light and sound treatment.
A pair of early stage clinical studies testing the safety and efficacy of 40Hz sensory stimulation to treat Alzheimer's disease has found that the potential therapy was well tolerated, produced no serious adverse effects and was associated with some significant neurological and behavioral benefits among a small cohort of participants.